Today it was announced that pharmaceuticals are not exempt from Trump’s tariffs. How does this apply to medical devices? Are most devices manufactured offshore? Mr. Wittes: It’s company by company, ...

Please tell us about Puma Biotechnology. Mr. Auerbach: I’d be more than happy to. Puma is a biotech company that is dedicated to the development and commercialization of drugs for the treatment of ...

Please give us an overview of BioHarvest and its products and services. Mr. Sobel: I have the privilege of being CEO of BioHarvest Sciences. BioHarvest Sciences is the global leader in plant cell ...

We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two assets that we are currently ...

Let’s start with an overview of the company and some notable milestones. Mr. Levy: Sure. You know, a major challenge for cancer patients and their caregivers today is that while we’ve seen incredible ...

Let’s start with a look at your coverage, and how it might have changed since we spoke in 2023. Mr. Lichtman: Sure. I cover a large group of medical device companies from micro cap to mega cap. I ...

Please give us a brief overview of NeurAxis and its services. Mr. Carrico: Sure. NeurAxis is an early growth stage med-tech company, focused on treating disorders of the gut-brain interaction in the ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Bear market investing protection from Jeremy A. Ellis of Campbell Newman Asset Management and Jeffrey Lent, Torray Investment ...

Jeffrey D. Lent is a Partner at Torray Investment Partners and the Portfolio Manager for the Torray Equity Income strategy. He is also Co-Portfolio Manager of the Torray Fund (TORYX) and the firm ...

Jeremy A. Ellis, CFA, is a Portfolio Manager/Analyst at Campbell Newman Asset Management, Inc. He began his career in the investment management industry in 2007. Mr. Ellis joined Campbell Newman ...